Oaktree Acquisition Corp. III Life Sciences (OACC) Form 10-Q — May 13, 2026
Oaktree Acquisition Corp. III Life Sciences, a pre-deal SPAC, reported a net income of $1,394,121 for the quarter ended March 31, 2026. This income primarily consists of interest earned on cash held in the trust account, offset by general and administrative expenses. As of March 31, 2026, the company had $1,276,930 in cash outside the trust account and $203,414,191 held in the trust account.
Key figures
- Net Income
- 1394121
- Total Debt
- 0
- Cash Position
- 1276930
- Cash Held In Trust Account
- 203414191
Price after filing
1 day: 0.0%7 days: +0.6%30 days: +0.2%
Close on the filing date to close N calendar days later (from $10.64). Historical, not a forecast.
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.